Combined Liver Stiffness and Α-fetoprotein Further beyond the Sustained Virologic Response Visit as Predictors of Long-Term Liver-Related Events in Patients with Chronic Hepatitis C

被引:1
作者
Chen, Sheng-Hung [1 ,2 ]
Lai, Hsueh-Chou [2 ,3 ]
Su, Wen-Pang [2 ]
Kao, Jung-Ta [1 ,2 ]
Chuang, Po-Heng [2 ]
Hsu, Wei-Fan [2 ,3 ]
Wang, Hung-Wei [1 ,2 ]
Hsieh, Tsung-Lin [2 ]
Chen, Hung-Yao [1 ,2 ]
Peng, Cheng-Yuan [1 ,2 ]
机构
[1] China Med Univ, Dept Med, Taichung, Taiwan
[2] China Med Univ Hosp, Ctr Digest Med, Dept Internal Med, Taichung, Taiwan
[3] China Med Univ, Dept Chinese Med, Taichung, Taiwan
关键词
HEPATOCELLULAR-CARCINOMA; ANTIVIRAL THERAPY; ALPHA-FETOPROTEIN; SURVEILLANCE; DIAGNOSIS; CIRRHOSIS; UPDATE;
D O I
10.1155/2022/5201443
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Aims. Long-term risk stratification using combined liver stiffness (LS) and clinically relevant blood tests acquired at the baseline further beyond the sustained virologic response (SVR) visit for chronic hepatitis C (CHC) has not been thoroughly investigated. This study retrospectively investigated the prognostics of liver-related events (LREs) further beyond the SVR visit. Methods. Cox regression and random forest models identified the key factors, including longitudinal LS and noninvasive test results, that could predict LREs, including hepatocellular carcinoma, during prespecified follow-ups from 2010 to 2021. Kaplan-Meier survival analysis estimated the significance of between-group risk stratification. Results. Of the entire eligible cohort (n = 520) of CHC patients with SVR to antiviral therapy, 28 (5.4%) patients developed post-SVR LREs over a median follow-up period of 6.1 years (interquartile range = 3.5-8.7). The multivariate Cox regression analysis identified two significant predictors of LREs after the year 3 post-SVR (Y3PSVR) baseline (LRE, n = 15 of 28, 53.6%, median follow-up = 4.1 [1.6-6.4] years after Y3PSVR): LS at Y3PSVR (adjusted hazard ratio [aHR] = 3.980, 95% confidence interval [CI] = 2.085-7.597, P < 0.001), and alpha-fetoprotein (AFP) at Y3PSVR (aHR = 1.017, 95% CI = 1.001-1.034, P=0.034). LS & GE;1.45 m/s and AFP & GE;3.00 ng/mL for Y3PSVR yielded positive likelihood ratios of 4.24 and 2.62, respectively. Kaplan-Meier analysis revealed that among the stratified subgroups, the subgroup with concurrent LS & GE;1.45 m/s and AFP & GE;3.00 ng/mL at Y3PSVR exhibited the highest risk of LREs after Y3PSVR (log-rank P < 0.001). Conclusion. We recommend the combined use of concurrent LS and AFP in future prediction models for LREs in CHC. Patients with concurrently high LS and AFP values further beyond the SVR visit may require a recall policy involving intense surveillance.
引用
收藏
页数:14
相关论文
共 41 条
[1]   Update to the Society of Radiologists in Ultrasound Liver Elastography Consensus Statement [J].
Barr, Richard G. ;
Wilson, Stephanie R. ;
Rubens, Deborah ;
Garcia-Tsao, Guadalupe ;
Ferraioli, Giovanna .
RADIOLOGY, 2020, 296 (02) :263-274
[2]   EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis-2021 update [J].
Berzigotti, Annalisa ;
Tsochatzis, Emmanouil ;
Boursier, Jerome ;
Castera, Laurent ;
Cazzagon, Nora ;
Friedrich-Rust, Mireen ;
Petta, Salvatore ;
Thiele, Maja .
JOURNAL OF HEPATOLOGY, 2021, 75 (03) :659-689
[3]   Liver and Spleen Stiffness Surveillance Through Elastography During and After Direct-Acting Antiviral Therapy in Patients With Chronic Hepatitis C [J].
Chen, Sheng-Hung ;
Lai, Hsueh-Chou ;
Su, Wen-Pang ;
Kao, Jung-Ta ;
Chuang, Po-Heng ;
Hsu, Wei-Fan ;
Wang, Hung-Wei ;
Tsai, Tsung-Yu ;
Chen, Hung-Yao ;
Peng, Cheng-Yuan .
JOURNAL OF ULTRASOUND IN MEDICINE, 2022, 41 (05) :1169-1177
[4]   Liver fibrosis regression correlates with downregulation in liver angiogenesis in chronic hepatitis C through viral eradication [J].
Chen, Sheng-Hung ;
Huang, Chia-Lin ;
Chiang, I-Ping ;
Chang, Tzu-Ching ;
Wang, Hung-Wei ;
Hsu, Wei-Fan ;
Tsai, Tsung-Yu ;
Peng, Cheng-Yuan .
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 33 (09) :1209-1217
[5]   Performance of Acoustic Radiation Force Impulse Elastography for Staging Liver Fibrosis in Patients With Chronic Hepatitis C After Viral Eradication [J].
Chen, Sheng-Hung ;
Lai, Hsueh-Chou ;
Chiang, I-Ping ;
Su, Wen-Pang ;
Lin, Chia-Hsin ;
Kao, Jung-Ta ;
Chuang, Po-Heng ;
Hsu, Wei-Fan ;
Wang, Hung-Wei ;
Chen, Hung-Yao ;
Huang, Guan-Tarn ;
Peng, Cheng-Yuan .
CLINICAL INFECTIOUS DISEASES, 2020, 70 (01) :114-122
[6]   Liver Stiffness at the Time of Sustained Virological Response Predicts the Clinical Outcome in People Living With Human Immunodeficiency Virus and Hepatitis C Virus With Advanced Fibrosis Treated With Direct-acting Antivirals [J].
Corma-Gomez, A. ;
Macias, J. ;
Tellez, F. ;
Freyre-Carrillo, C. ;
Morano, L. ;
Rivero-Juarez, A. ;
Rios, M. J. ;
Alados, J. C. ;
Vera-Mendez, F. J. ;
Merchante, N. ;
Palacios, R. ;
Granados, R. ;
Merino, D. ;
De Los Santos, I ;
Pineda, J. A. .
CLINICAL INFECTIOUS DISEASES, 2020, 71 (09) :2354-2362
[7]   Towards a new definition of decompensated cirrhosis [J].
D'Amico, Gennaro ;
Bernardi, Mauro ;
Angeli, Paolo .
JOURNAL OF HEPATOLOGY, 2022, 76 (01) :202-207
[8]   Risk of hepatocellular carcinoma after HCV eradication: Determining the role of portal hypertension by measuring spleen stiffness [J].
Dajti, Elton ;
Marasco, Giovanni ;
Ravaioli, Federico ;
Colecchia, Luigi ;
Ferrarese, Alberto ;
Festi, Davide ;
Colecchia, Antonio .
JHEP REPORTS, 2021, 3 (03)
[9]   Spleen Stiffness Measurements Predict the Risk of Hepatic Decompensation After Direct-Acting Antivirals in HCV Cirrhotic Patients [J].
Dajti, Elton ;
Ravaioli, Federico ;
Colecchia, Antonio ;
Marasco, Giovanni ;
Reggiani, Maria Letizia Bacchi ;
Colli, Agostino ;
Alemanni, Luigina Vanessa ;
Tame, Mariarosa ;
Andreone, Pietro ;
Brillanti, Stefano ;
Azzaroli, Francesco ;
Mazzella, Giuseppe ;
Festi, Davide .
ULTRASCHALL IN DER MEDIZIN, 2022, 43 (03) :280-288
[10]  
Demsar J, 2013, J MACH LEARN RES, V14, P2349